Progress in combating lymphatic filariasis is significant, yet challenges remain. Mass drug administration plays a crucial role in preventing new infections and halting disease progression, benefiting over 58 million individuals. However, quantifying the success of public health initiatives can be complex, as it often involves measuring what doesn’t happen rather than tangible outcomes.
